Covered recipient · General Payments record
ASTHA NARENDRAKUMAR UPADHYAYA
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2025
$255.62
- Reported across 10 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $255.62 | 10 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BridgeBio Pharma, Inc. | $165.36 | 6 |
| ABIOMED | $32.59 | 1 |
| Alnylam Pharmaceuticals Inc. | $26.03 | 1 |
| Acerta Pharma LLC | $15.82 | 1 |
| Amgen Inc. | $15.82 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $255.62 | 10 |
Payment records · PY2025 (10)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $32.59 | 09/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174370986 | CMS |
| Alnylam Pharmaceuticals Inc. | $26.03 | 08/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1212745423 | CMS |
| Amgen Inc. | $15.82 | 09/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228262465 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.82 | 08/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206345043 | CMS |
| BridgeBio Pharma, Inc. | $9.82 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250441608 | CMS |
| BridgeBio Pharma, Inc. | $8.66 | 08/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250441610 | CMS |
| BridgeBio Pharma, Inc. | $9.10 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250441606 | CMS |
| BridgeBio Pharma, Inc. | $8.61 | 10/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250441614 | CMS |
| BridgeBio Pharma, Inc. | $119.36 | 12/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250441616 | CMS |
| BridgeBio Pharma, Inc. | $9.81 | 12/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250441612 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.